vs
Side-by-side financial comparison of Ellington Credit Co (EARN) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.
Ellington Credit Co is the larger business by last-quarter revenue ($6.1M vs $4.9M, roughly 1.2× Sensus Healthcare, Inc.). Ellington Credit Co runs the higher net margin — -32.6% vs -64.1%, a 31.5% gap on every dollar of revenue. On growth, Ellington Credit Co posted the faster year-over-year revenue change (1528.9% vs -62.2%). Over the past eight quarters, Ellington Credit Co's revenue compounded faster (6.3% CAGR vs -31.9%).
Ellington Management Group is an American hedge fund firm. As of June 2019, the firm was reportedly managing $8.5 billion in structured products and other credit instruments.
Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.
EARN vs SRTS — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.1M | $4.9M |
| Net Profit | $-2.0M | $-3.2M |
| Gross Margin | — | 38.4% |
| Operating Margin | -35.6% | -63.8% |
| Net Margin | -32.6% | -64.1% |
| Revenue YoY | 1528.9% | -62.2% |
| Net Profit YoY | -116.1% | -304.9% |
| EPS (diluted) | — | $-0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $4.9M | ||
| Q3 25 | — | $6.9M | ||
| Q2 25 | — | $7.3M | ||
| Q1 25 | — | $8.3M | ||
| Q4 24 | $6.1M | $13.1M | ||
| Q3 24 | $4.8M | $8.8M | ||
| Q2 24 | $3.9M | $9.2M | ||
| Q1 24 | — | $10.7M |
| Q4 25 | — | $-3.2M | ||
| Q3 25 | — | $-943.0K | ||
| Q2 25 | — | $-1.0M | ||
| Q1 25 | — | $-2.6M | ||
| Q4 24 | $-2.0M | $1.5M | ||
| Q3 24 | $5.4M | $1.2M | ||
| Q2 24 | $-815.0K | $1.6M | ||
| Q1 24 | — | $2.3M |
| Q4 25 | — | 38.4% | ||
| Q3 25 | — | 39.4% | ||
| Q2 25 | — | 39.7% | ||
| Q1 25 | — | 52.2% | ||
| Q4 24 | — | 54.4% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 58.7% | ||
| Q1 24 | — | 62.5% |
| Q4 25 | — | -63.8% | ||
| Q3 25 | — | -37.3% | ||
| Q2 25 | — | -26.6% | ||
| Q1 25 | — | -31.7% | ||
| Q4 24 | -35.6% | 13.2% | ||
| Q3 24 | — | 16.9% | ||
| Q2 24 | -22.8% | 21.5% | ||
| Q1 24 | — | 27.1% |
| Q4 25 | — | -64.1% | ||
| Q3 25 | — | -13.7% | ||
| Q2 25 | — | -14.2% | ||
| Q1 25 | — | -30.8% | ||
| Q4 24 | -32.6% | 11.8% | ||
| Q3 24 | 114.6% | 13.7% | ||
| Q2 24 | -20.9% | 17.4% | ||
| Q1 24 | — | 21.3% |
| Q4 25 | — | $-0.19 | ||
| Q3 25 | — | $-0.06 | ||
| Q2 25 | — | $-0.06 | ||
| Q1 25 | — | $-0.16 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | — | $0.07 | ||
| Q2 24 | — | $0.10 | ||
| Q1 24 | — | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.8M | $22.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $193.7M | $48.1M |
| Total Assets | $824.1M | $53.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $22.1M | ||
| Q3 25 | — | $24.5M | ||
| Q2 25 | — | $22.2M | ||
| Q1 25 | — | $19.1M | ||
| Q4 24 | $31.8M | $22.1M | ||
| Q3 24 | $25.7M | $22.6M | ||
| Q2 24 | $118.8M | $19.0M | ||
| Q1 24 | — | $14.7M |
| Q4 25 | — | $48.1M | ||
| Q3 25 | — | $51.2M | ||
| Q2 25 | — | $52.1M | ||
| Q1 25 | — | $53.0M | ||
| Q4 24 | $193.7M | $55.8M | ||
| Q3 24 | $191.6M | $54.1M | ||
| Q2 24 | $146.1M | $52.9M | ||
| Q1 24 | — | $51.2M |
| Q4 25 | — | $53.0M | ||
| Q3 25 | — | $58.3M | ||
| Q2 25 | — | $58.9M | ||
| Q1 25 | — | $60.2M | ||
| Q4 24 | $824.1M | $62.2M | ||
| Q3 24 | $752.3M | $59.9M | ||
| Q2 24 | $933.5M | $58.2M | ||
| Q1 24 | — | $57.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $-2.2M |
| Free Cash FlowOCF − Capex | — | $-2.4M |
| FCF MarginFCF / Revenue | — | -47.9% |
| Capex IntensityCapex / Revenue | — | 3.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $332.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-2.2M | ||
| Q3 25 | — | $2.3M | ||
| Q2 25 | — | $3.1M | ||
| Q1 25 | — | $-2.7M | ||
| Q4 24 | $4.4M | $-827.0K | ||
| Q3 24 | $3.2M | $4.0M | ||
| Q2 24 | $2.7M | $4.2M | ||
| Q1 24 | — | $-8.2M |
| Q4 25 | — | $-2.4M | ||
| Q3 25 | — | $2.3M | ||
| Q2 25 | — | $3.1M | ||
| Q1 25 | — | $-2.7M | ||
| Q4 24 | — | $-1.1M | ||
| Q3 24 | — | $3.6M | ||
| Q2 24 | — | $4.2M | ||
| Q1 24 | — | $-8.4M |
| Q4 25 | — | -47.9% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 42.2% | ||
| Q1 25 | — | -32.2% | ||
| Q4 24 | — | -8.6% | ||
| Q3 24 | — | 40.9% | ||
| Q2 24 | — | 45.8% | ||
| Q1 24 | — | -79.0% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 2.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.53× | ||
| Q3 24 | 0.60× | 3.25× | ||
| Q2 24 | — | 2.62× | ||
| Q1 24 | — | -3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EARN
Segment breakdown not available.
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
